Step 1: Understanding plasma protein binding. Many drugs bind to plasma proteins, primarily albumin. Only the free (unbound) drug is available for pharmacological action. The protein-bound fraction serves as a reservoir, gradually releasing the drug as the free form is metabolized or excreted.
Step 2: Pharmacodynamic and pharmacokinetic implications.
- Pharmacodynamically inert: Since bound drugs cannot interact with receptors or target tissues, they are pharmacodynamically inactive.
- Pharmacokinetically active: Plasma-bound drugs can influence drug distribution and half-life but are not inert in pharmacokinetic terms.
Step 3: Why other options are incorrect. - (A) Pharmacodynamically active: Incorrect, as only free drugs interact with receptors.
- (B) Pharmacokinetically inert: Incorrect, as binding affects drug distribution and elimination.
- (C) Pharmacokinetically and pharmacodynamically inert: Incorrect, because plasma-bound drugs influence pharmacokinetics but not pharmacodynamics.
| List I-Drugs | List II-Classes | ||
| A | Anakinra | I | IL‐2 receptor antagonist |
| B | Basiliximab | II | TNFα inhibitors |
| C | Infliximab | III | Calcineurin inhibitors |
| D | Tacrolimus | IV | mTOR inhibitors |
| E | - | V | IL‐1 receptor antagonist |
Choose the correct answer from the options given below:
| List I-(Poisoning) | List II-(Treatment) | ||
| A | Warfarin | I | Pralidoxime |
| B | Carbon monoxide | II | Oxygen |
| C | Cyanide | III | Vitamin K |
| D | Nitrites | IV | Dicobalt edatate |
| E | Organophosphates | V | Methylene blue |
List I | List II | ||
|---|---|---|---|
| A | \(\Omega^{-1}\) | I | Specific conductance |
| B | \(∧\) | II | Electrical conductance |
| C | k | III | Specific resistance |
| D | \(\rho\) | IV | Equivalent conductance |
List I | List II | ||
|---|---|---|---|
| A | Constant heat (q = 0) | I | Isothermal |
| B | Reversible process at constant temperature (dT = 0) | II | Isometric |
| C | Constant volume (dV = 0) | III | Adiabatic |
| D | Constant pressure (dP = 0) | IV | Isobar |